martes, 12 de noviembre de 2024

Efficacy and safety of gefapixant in women with chronic cough and cough-induced stress urinary incontinence: a phase 3b, randomised, multicentre, double-blind, placebo-controlled trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00222-4/abstract?utm_campaign=update-lanres&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanres&_hsenc=p2ANqtz-9U90hd3nP2wDROnGN9qypJ1iIDZrbrj3SFmTvKMbLoYrEETqrucj_LPPyHFTdi_X2n_q5dYFnj7VBl_XNQUXop2HJn4Q&_hsmi=333370133&utm_content=333357343&utm_source=hs_email

No hay comentarios:

Publicar un comentario